CU Heme Logo

The

Robert H. Allen

Memorial

Hematology Symposia

The

Robert H. Allen

Memorial

Hematology Symposia

A series for continuing education - free to those who register.

BROADCAST FROM DENVER, COLORADO | NEXT SESSION FALL 2024

Dr. Robert Allen

Dr. Allen served as the Division of Hematology Chief for nearly 40 years at University of Colorado. He dedicated his life to educating the future generation of hematologists.

Dr. Allen served as the Division of Hematology Chief for nearly 40 years at University of Colorado. He dedicated his life to educating the future generation of hematologists.

MEET THE Hematology Symposia
PRESENTERS
2023 - 2024

2023 - 2022
Hematology Symposia
PRESENTERS

Management of Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia in the Era of Novel Immunotherapy: Case-based Discussion

***

Mantle Cell Lymphoma: Challenges & Prospects

***

Oncological Emergencies in Acute Myeloid Leukemia

This presentation will discuss the common oncological emergencies and complications associated with newly diagnosed or relapsed and/or refractory AML. This will include the diagnosis, prevention and acute management of AML complications.

Evaluation of Generalized Joint Hypermobility in Individuals with Abnormal Bleeding

This presentation will discuss the pathophysiology of connective tissue/collagen vascular disease as it relates to abnormal bleeding symptoms and review the screening tools that hematologists, primary care providers, and gynecologists should be aware. I will also discuss the hematologists’ role in managing patients with generalized joint hypermobility.

Drug-Resistant Subpopulations in Patients with Multiple Myeloma

This presentation will discuss the treatment landscape for multiple myeloma, identify basic treatment sequencing in multiple myeloma and evaluate the potential roles of disease heterogeneity in disease response to treatment.  

Venetoclax and Transplant in AML: Oh, the
Places You'll Go!

This presentation will review the potential of venetoclax to enable and improve stem cell transplantation and to alter the paradigm of AML treatment.

Guidelines-based Management of Von Willebrand Disease

This presentation will provide health care professionals with tools to systematically assess and quantify patients’ bleeding symptoms.

Updates in Therapeutics for Sickle Cell

This presentation will discuss the inflammation pathway involved in the pathophysiology of sickle cell disease and the underlying drugs used to target the inflammation pathway.

Myeloid Malignancies and Novel Therapies

This presentation will review recent developments in the field of MDS and AML, discuss many of the new therapies approved and some that were not, and discuss promising future strategies that may be approved in the near future.

A Personalized Approach for T-cell Lymphomas

This presentation will review different clinical presentations and complications of TCLs, discuss different treatment options, and outcomes.

Sexual Dysfunction Following Stem Cell Transplant

This presentation will increase health care professionals’ knowledge about the prevalence of sexual dysfunction following stem cell transplant, contributors to sexual dysfunction, how and why these issues are often unaddressed, and assessment/intervention strategies to treat sexual dysfunction following transplant.

Rebecca Hunter, PhD